Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Cricut A	CRCT	26. nov 2024	5.17	-1.34
Crinetics Pharmaceuticals	CRNX	26. nov 2024	56.77	+1.21
CRISPR Therapeutics	CRSP	26. nov 2024	49.31	-2.16
Criteo ADR	CRTO	26. nov 2024	41.57	+3.87
Critical Metals	CRML	26. nov 2024	6.46	-0.15
Crocs	CROX	26. nov 2024	104.06	-4.12
Cronos Group	CRON	26. nov 2024	2.09	-1.88
Cross Country Healthcare	CCRN	26. nov 2024	10.66	-1.93
Cross Timbers Royalty Royalty Trust	CRT	26. nov 2024	10.85	+0.65
CrossAmerica Partners LP Unit	CAPL	26. nov 2024	20.26	-0.83
CrossFirst Bankshares	CFB	26. nov 2024	17.63	-1.78
CrowdStrike A	CRWD	26. nov 2024	364.30	+0.17
Crown Castle	CCI	26. nov 2024	106.30	+0.21
Crown Crafts	CRWS	26. nov 2024	4.60	+0.66
Crown ElectroKinetics	CRKN	26. nov 2024	0.31	-27.19
Crown Holdings	CCK	26. nov 2024	92.22	-0.43
Crown LNG	CGBS	26. nov 2024	0.32	-8.97
Cryo-Cell International	CCEL	26. nov 2024	9.00	+1.47
CryoPort	CYRX	26. nov 2024	7.18	+7.97
CS Disco	LAW	26. nov 2024	5.80	-1.86
CSG Systems International	CSGS	26. nov 2024	54.82	-0.72
CSP	CSPI	26. nov 2024	16.65	-9.95
CSW Industrials	CSWI	26. nov 2024	423.58	-1.95
CSX	CSX	26. nov 2024	36.69	+0.19
CTO Realty Growth	CTO	26. nov 2024	19.99	+0.65
CTO Realty Growth A Pref	CTO-A	26. nov 2024	23.52	-0.89
CTS	CTS	26. nov 2024	54.46	-1.82
CubeSmart	CUBE	26. nov 2024	49.92	+0.12
Cue Biopharma	CUE	26. nov 2024	1.09	+2.83
Cullen Frost Bankers B Pref	CFR-B	26. nov 2024	19.61	-0.73

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.